Intravenous administration of CP-4055 (ELACYT™) in patients with solid tumours. A phase I study

Author： Dueland Svein   Aamdal Steinar   Lind Michael   Thomas Hilary   Liland Sandvold Marit   Gaullier Jean-Michel   Rasch Wenche  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.48, Iss.1, 2009-01, pp. : 137-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins v 3 and v 5 in patients with advanced solid tumours

By Eskens F.A.L.M.   Dumez H.   Hoekstra R.   Perschl A.   Brindley C.   Bottcher S.   Wynendaele W.   Drevs J.   Verweij J.   van Oosterom A.T.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 917-926

Elsevier

Access to resources Recommend Favorite

Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours

By Crul M.   Rosing H.   de Klerk G.J.   Dubbelman R.   Traiser M.   Reichert S.   Knebel N.G.   Schellens J.H.M.   Beijnen J.H.   ten Bokkel Huinink W.W.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1615-1621

Elsevier

Access to resources Recommend Favorite

Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours

By Trocòniz Iñaki   Garrido María   Segura Cristina   Cendrós Josep-María   Principe Paola   Peraire Concepción   Obach Rosendo  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 727-735

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Multicenter Study of Continuous Oral Administration of Lonafarnib (SCH 66336) and Intravenous Gemcitabine in Patients With Advanced Cancer

By Wong Nan Soon   Meadows Kellen L.   Rosen Lee S.   Adjei Alex A.   Kaufmann Scott H.   Morse Michael A.   Petros William P.   Zhu Yali   Statkevich Paul   Cutler David L.   Meyers Michael L.   Hurwitz Herbert I.  

Cancer Investigation, Vol. 29, Iss. 9, 2011-10 ,pp. : 617-625

Informa Healthcare

Access to resources Recommend Favorite

Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumours

By Louwerens M.   Smorenburg C.   Sparreboom A.   Loos W.J.   Verweij J.   de Wit R.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 497-504

Elsevier

Access to resources Recommend Favorite